Feasibility Analysis of p62 (SQSTM1)—Encoding DNA Vaccine as a Novel Cancer Immunotherapy

Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector

(2015) Franco Venanzi et al.   Oncotarget

The Four Faces of Autophagy: Implications for Cancer Therapy

(2014) D. A. Gewirtz   CANCER RESEARCH

Cargo recognition and trafficking in selective autophagy

(2014) Alexandra Stolz et al.   NATURE CELL BIOLOGY

Non-viral vectors for gene-based therapy

(2014) Hao Yin et al.   NATURE REVIEWS GENETICS

Regulation of cell proliferation and migration by p62 through stabilization of Twist1

(2014) L. Qiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma

(2014) Amir Shlomai et al.   SEMINARS IN CANCER BIOLOGY

Tapping the treasure of intracellular oncotargets with immunotherapy

(2013) Cheng William Hong et al.   FEBS LETTERS

Prognostic Impact of p62 Expression in Cutaneous Malignant Melanoma

(2013) Robert A. Ellis et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines

(2013) Megan A. Chang et al.   PROSTATE

The human papillomavirus family and its role in carcinogenesis

(2013) Massimo Tommasino   SEMINARS IN CANCER BIOLOGY

Autophagy proteins in prostate cancer: Relation with anaerobic metabolism and Gleason score11The study was financially supported by the Tumor and Angiogenesis Research Group.

(2013) Alexandra Giatromanolaki et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

(2013) X Sui et al.   Cell Death & Disease

Trial watch

(2013) Laura Senovilla et al.   OncoImmunology

KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma

(2012) Jianhua Ling et al.   CANCER CELL

Awaiting a New Era of Cancer Immunotherapy

(2012) C. W. Hong et al.   CANCER RESEARCH

Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma

(2012) Daisuke Inoue et al.   CANCER SCIENCE

Recent progress in canine tumor vaccination: potential applications for human tumor vaccines

(2012) Sofie Denies et al.   Expert Review of Vaccines

The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells

(2012) S Galavotti et al.   ONCOGENE

Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells

(2011) Yoshihiro Inami et al.   JOURNAL OF CELL BIOLOGY

Targeting Intracellular Oncoproteins with Antibody Therapy or Vaccination

(2011) K. Guo et al.   Science Translational Medicine

Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice

(2010) Ke Guo et al.   CANCER BIOLOGY & THERAPY

Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer

(2010) Richard J Sylvester   INTERNATIONAL JOURNAL OF UROLOGY

p62/SQSTM1Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription

(2010) Ashish Jain et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation

(2010) Chan Gao et al.   NATURE CELL BIOLOGY

Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation

(2009) Y. Hiruma et al.   BLOOD

p62 at the Crossroads of Autophagy, Apoptosis, and Cancer

(2009) Jorge Moscat et al.   CELL

Autophagy Suppresses Tumorigenesis through Elimination of p62

(2009) Robin Mathew et al.   CELL

A Role for NBR1 in Autophagosomal Degradation of Ubiquitinated Substrates

(2009) Vladimir Kirkin et al.   MOLECULAR CELL

Importance of mRNA Secondary Structural Elements for the Expression of Influenza Virus Genes

(2009) Petr O. Ilyinskii et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis

(2008) Angeles Duran et al.   CANCER CELL

Development of a Vaccine Against Pandemic Influenza Viruses: Current Status and Perspectives

(2008) Petr O. Ilyinskii et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS

Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency

(2008) Petr O. Ilyinskii et al.   PLoS One

Adjuvant potential of aggregate-forming polyglutamine domains

(2008) P.O. Ilyinskii et al.   VACCINE

Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response

(2008) P.O. Ilyinskii et al.   VACCINE